SECONDARY OSTEOSARCOMA

Clinical trials for SECONDARY OSTEOSARCOMA explained in plain language.

Never miss a new study

Get alerted when new SECONDARY OSTEOSARCOMA trials appear

Sign up with your email to follow new studies for SECONDARY OSTEOSARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Major trial aims to boost survival for young bone cancer patients

Disease control Recruiting now

This large study is testing if adding a newer drug called cabozantinib to standard chemotherapy works better for treating newly diagnosed osteosarcoma, a type of bone cancer. It will involve over 1,100 patients under 40 years old, comparing the new combination against standard ch…

Matched conditions: SECONDARY OSTEOSARCOMA

Phase: PHASE2, PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 30, 2026 14:33 UTC

SECONDARY OSTEOSARCOMA

Get alerted when new SECONDARY OSTEOSARCOMA trials appear

Major trial aims to boost survival for young bone cancer patients